部分miRNA在糖尿病性心肌病病理生理过程中的作用(4)
[7] Chen S，Puthanveetil P，Feng B，et al.Cardiac miR-133a overexpression prevents early cardiac fibrosis in diabetes[J].J Cell Mol Med，2014，18(3)：415-421.
[8] Falcao-Pires I，Leite-Moreira A F.Diabetic cardiomyopathy：understanding the molecular and cellular basis to progress in diagnosis and treatment[J].Heart Fail Rev，2012，17(3)：325-344.
[9] Gulati A，Jabbour A，Ismail T F，et al.Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy[J].JAMA，2013，309(9)：896-908.
, http://www.100md.com
[10] Cheng Y，Zhang D，Zhu M，et al.Liver X receptor alpha is targeted by microRNA-1 to inhibit cardiomyocyte apoptosis through ROS-mediated mitochondrial pathway[J].Biochem Cell Biol，2018，96(1)：11-18.
[11] Dludla P V，Nkambule B B，Dias S C，et al.Cardioprotective potential of N-acetyl cysteine against hyperglycaemia-induced oxidative damage：a protocol for a systematic review[J].Syst Rev，2017，6(1)：96.
[12] Li D，Liu M，Tao T Q，et al.Panax quinquefolium saponin attenuates cardiomyocyte apoptosis and opening of the mitochondrial permeability transition pore in a rat model of ischemia/reperfusion[J].Cell Physiol Biochem，2014，34(4)：1413-1426.
, 百拇医药
[13] Zhai C，Tang G，Peng L，et al.Inhibition of microRNA-1 attenuates hypoxia/re-oxygenation-induced apoptosis of cardiomyocytes by directly targeting Bcl-2 but not GADD45Beta[J].Am J Transl Res，2015，7(10)：1952-1962.
[14] Feng B，Chakrabarti S.miR-320 Regulates Glucose-Induced Gene Expression in Diabetes[J].ISRN Endocrinol，2012，2012：549875.
[15] Chen S，Puthanveetil P，Feng B，et al.Cardiac miR-133a overexpression prevents early cardiac fibrosis in diabetes[J].J Cell Mol Med，2014，18(3)：415-421.
, http://www.100md.com
[16] de Gonzalo-Calvo D，van der Meer R W，Rijzewijk L J，et al.
Serum microRNA-1 and microRNA-133a levels reflect myocardial steatosis in uncomplicated type 2 diabetes[J].Sci Rep，2017，7(1)：47.
[17] Li Y，Yang C M，Xi Y，et al.MicroRNA-1/133 targeted dysfunction of potassium channels KCNE1 and KCNQ1 in human cardiac progenitor cells with simulated hyperglycemia[J].Int J Cardiol，2013，167(3)：1076-1078.
, 百拇医药 [18] de Gonzalo-Calvo D，Iglesias-Gutierrez E，Llorente-Cortes V.
Epigenetic Biomarkers and Cardiovascular Disease：Circulating MicroRNAs[J].Rev Esp Cardiol(Engl Ed)，2017，70(9)：763-769.
[19] Lorenzen J，Kumarswamy R，Dangwal S，et al.MicroRNAs in diabetes and diabetes-associated complications[J].RNA Biology，2014，9(6)：820-827.
[20] Chavali V，Tyagi S C，Mishra P K.Predictors and prevention of diabetic cardiomyopathy[J].Diabetes Metab Syndr Obes，2013，6：151-160., http://www.100md.com(叶小林 李涛 吴柱国)
[8] Falcao-Pires I，Leite-Moreira A F.Diabetic cardiomyopathy：understanding the molecular and cellular basis to progress in diagnosis and treatment[J].Heart Fail Rev，2012，17(3)：325-344.
[9] Gulati A，Jabbour A，Ismail T F，et al.Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy[J].JAMA，2013，309(9)：896-908.
, http://www.100md.com
[10] Cheng Y，Zhang D，Zhu M，et al.Liver X receptor alpha is targeted by microRNA-1 to inhibit cardiomyocyte apoptosis through ROS-mediated mitochondrial pathway[J].Biochem Cell Biol，2018，96(1)：11-18.
[11] Dludla P V，Nkambule B B，Dias S C，et al.Cardioprotective potential of N-acetyl cysteine against hyperglycaemia-induced oxidative damage：a protocol for a systematic review[J].Syst Rev，2017，6(1)：96.
[12] Li D，Liu M，Tao T Q，et al.Panax quinquefolium saponin attenuates cardiomyocyte apoptosis and opening of the mitochondrial permeability transition pore in a rat model of ischemia/reperfusion[J].Cell Physiol Biochem，2014，34(4)：1413-1426.
, 百拇医药
[13] Zhai C，Tang G，Peng L，et al.Inhibition of microRNA-1 attenuates hypoxia/re-oxygenation-induced apoptosis of cardiomyocytes by directly targeting Bcl-2 but not GADD45Beta[J].Am J Transl Res，2015，7(10)：1952-1962.
[14] Feng B，Chakrabarti S.miR-320 Regulates Glucose-Induced Gene Expression in Diabetes[J].ISRN Endocrinol，2012，2012：549875.
[15] Chen S，Puthanveetil P，Feng B，et al.Cardiac miR-133a overexpression prevents early cardiac fibrosis in diabetes[J].J Cell Mol Med，2014，18(3)：415-421.
, http://www.100md.com
[16] de Gonzalo-Calvo D，van der Meer R W，Rijzewijk L J，et al.
Serum microRNA-1 and microRNA-133a levels reflect myocardial steatosis in uncomplicated type 2 diabetes[J].Sci Rep，2017，7(1)：47.
[17] Li Y，Yang C M，Xi Y，et al.MicroRNA-1/133 targeted dysfunction of potassium channels KCNE1 and KCNQ1 in human cardiac progenitor cells with simulated hyperglycemia[J].Int J Cardiol，2013，167(3)：1076-1078.
, 百拇医药 [18] de Gonzalo-Calvo D，Iglesias-Gutierrez E，Llorente-Cortes V.
Epigenetic Biomarkers and Cardiovascular Disease：Circulating MicroRNAs[J].Rev Esp Cardiol(Engl Ed)，2017，70(9)：763-769.
[19] Lorenzen J，Kumarswamy R，Dangwal S，et al.MicroRNAs in diabetes and diabetes-associated complications[J].RNA Biology，2014，9(6)：820-827.
[20] Chavali V，Tyagi S C，Mishra P K.Predictors and prevention of diabetic cardiomyopathy[J].Diabetes Metab Syndr Obes，2013，6：151-160., http://www.100md.com(叶小林 李涛 吴柱国)
参见：首页 > 医疗版 > 疾病专题 > 内分泌科 > 糖尿病